title: Acarbose: an alternative to metformin for first-line treatment in type 2 diabetes?
authors.affiliation: Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong Special Administrative Region, China; The Li Ka Shing Institute of Health Sciences, Hong Kong Special Administrative Region, China; Hong Kong Institute of Diabetes and Obesity, Chinese University of Hong Kong, Hong Kong Special Administrative Region, China. Electronic address: rcwma@cuhk.edu.hk.
authors.forename: Ronald C W
authors.initials: RC
authors.lastname: Ma
mesh_terms: D020909:Acarbose / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D008687:Metformin / Q000627:therapeutic use*
chemical_list: D007004:Hypoglycemic Agents; D008687:Metformin; D020909:Acarbose